by Eric Christianson | Jul 12, 2020 | Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
Sodium-glucose co-transporter 2 inhibitors (SGLT2s) are becoming popular treatments for type 2 diabetes mellitus. While typically classified as diabetes medications, there is more and more research coming out for their benefits in cardiovascular health and heart...
by Eric Christianson | Jul 8, 2020 | Medication and Disease State Clinical Pearls For Pharmacists, Respiratory Medication and Disease State Clinical Pearls
Pulmonary toxicology involves the airways, lung parenchyma, mediastinum, pleura, pulmonary vasculature, and the neuromuscular system based on the route of exposure to the offending agent and the dose and duration of exposure. Acute pulmonary reactions are commonly...
by Eric Christianson | Jul 5, 2020 | Clinical Guideline Updates For Pharmacists
Recently, the International Society of Hypertension released its 2020 blood pressure guidelines. Their guidelines do vary a little bit from the 2017 ACC/AHA guidelines that were put out a few years ago. Here are a few of the important highlights from the ISH 2020...
by Eric Christianson | Jul 1, 2020 | Educational Case Studies For Pharmacists, Polypharmacy Cases And The Prescribing Cascade
I often find patients on numerous bedtime cocktails and this is often a situation where medications were slowly added over time for recurring symptoms of the same syndrome. A 79-year-old female at a long term care facility has had a long history of having aches and...
by Eric Christianson | Jun 28, 2020 | Cardiovascular Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
On a previous post, I discussed some issues surrounding digoxin use in CHF. In this post, I wanted to cover strategies for managing an out of range digoxin level. Digoxin is a drug that we can and do often assess drug levels. In clinical practice, checking levels for...
